![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0035.jpg)
partners and other stakeholders
for their efforts and contribution
in the past year and to you, our
shareholders, for your continued
support and confidence.
Thank you.
Dato’ Roslan bin Hamir
Group Managing Director
We expect our
bulking and food
businesses to
deliver organic
growth
through
further investments
and improvement
in their customer
offerings and market
expansion.
Introducing our new Chairman
I hope to bring all this to bear in helping to craft a way forward for
the Group and supplementing the already diverse and considerable
skills of my Board colleagues. There is strength in diversity, both at
Board and team levels, and I look forward to working with them all.
The year ahead is expected to present heightened challenges and
uncertainties of global economic growth following US-China trade
tension and protracted Brexit negotiations. While we will not be
immune from its effects, our businesses have shown resilience in the
past and I am confident that the quality of our assets and balance
sheet, along with the skills of our 3,000-strong workforce, will
ensure that the Group can stand up to near-term challenges and
external headwinds.
The Group’s FYE2019 performance is covered in further detail in
this Annual Report. It is a story of growth and resilience across the
portfolio, which gives me as well as my fellow Board members, the
conviction that the best years lie ahead. I very much look forward to
reporting to you on our continued progress.
Thank you.
Dato’ Idris bin Kechot
Chairman
Dear Shareholders,
I
became Chairman of the Company on
26 June 2019, having been earlier
appointed to the Board as an
Independent Non-Executive Director
on 3 May 2019. It is indeed a special
privilege for me to take on the
role of Chairman at a company
that is already built on a strong
foundation from which to
grow and essential to long-
term value creation. For that,
I wish to pay tribute to my
predecessor and acknowledge
the commitment of my fellow
Directors for steering the Group
and maintaining its robust health.
performance
review
31